Description
Tirz (Tirzepatide) is a dual GIP and GLP-1 receptor agonist being investigated in laboratory studies for its potential role in metabolic health research. By engaging both incretin hormone pathways, it has shown the ability to influence glucose homeostasis, energy expenditure, and food intake regulation in non-human studies.
Key Research Notes:
•Dual agonist mechanism targets both GIP and GLP-1 receptors
•May impact glucose regulation, insulin dynamics, and energy balance in laboratory models
•Manufactured to strict purity standards for reliable research results
Disclaimer:
For research use only. Not for human consumption, medical, or veterinary use
Reviews
There are no reviews yet.